Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
Mitogen-activated protein kinase kinase kinase 12 (MAP3K12)
|
|
35.366 (58/164) |
2.37E-20 |
Tyrosine-protein kinase ABL1 (ABL)
|
|
27.376 (72/263) |
1.19E-19 |
Proto-oncogene c-Fes (FES)
|
|
28.571 (74/259) |
1.75E-19 |
Mitogen-activated protein kinase kinase kinase 13 (MAP3K13)
|
|
36.842 (49/133) |
8.70E-19 |
Tyrosine-protein kinase CSK (CSK)
|
|
24.904 (65/261) |
4.39E-18 |
Titin (TTN)
|
24.719 (66/267) |
1.00E-17 |
Tyrosine-protein kinase BMX (BMX)
|
|
26.360 (63/239) |
1.81E-17 |
Tyrosine-protein kinase ABL2 (ABL2)
|
|
26.800 (67/250) |
2.86E-17 |
Proto-oncogene c-Ret (RET)
|
|
26.596 (75/282) |
3.38E-17 |
Tyrosine-protein kinase BRK (PTK6)
|
|
27.273 (66/242) |
1.04E-16 |
Fibroblast growth factor receptor 4 (FGFR4)
|
|
25.391 (65/256) |
2.10E-16 |
Tyrosine-protein kinase Lyn (JTK8)
|
|
27.237 (70/257) |
2.40E-16 |
Fibroblast growth factor receptor 1 (FGFR1)
|
|
27.007 (74/274) |
5.72E-16 |
Tyrosine-protein kinase FRK (FRK)
|
|
26.766 (72/269) |
6.23E-16 |
Fibroblast growth factor receptor 2 (FGFR2)
|
|
26.022 (70/269) |
8.77E-16 |
Hematopoietic cell kinase (HCK)
|
|
26.172 (67/256) |
1.16E-15 |
Tyrosine-protein kinase BTK (ATK)
|
|
28.571 (58/203) |
1.62E-15 |
Megakaryocyte-associated tyrosine-protein kinase (MATK)
|
|
25.110 (57/227) |
2.69E-15 |
Tyrosine-protein kinase Tec (PSCTK4)
|
|
26.339 (59/224) |
2.77E-15 |
Proto-oncogene c-RAF (c-RAF)
|
|
24.679 (77/312) |
3.13E-15 |
Proto-oncogene c-Src (SRC)
|
|
23.016 (58/252) |
3.16E-15 |
Receptor-interacting protein 1 (RIPK1)
|
|
22.414 (52/232) |
5.31E-15 |
Serine/threonine-protein kinase A-Raf (ARAF)
|
|
25.911 (64/247) |
1.45E-14 |
T-cell-specific kinase (ITK)
|
|
23.188 (64/276) |
2.13E-14 |
Tie-1 tyrosine kinase receptor (TIE1)
|
|
25.000 (65/260) |
2.22E-14 |
Ephrin type-B receptor 2 (EPHB2)
|
|
25.095 (66/263) |
2.51E-14 |
TGF-beta-activated kinase 1 (MAP3K7)
|
|
30.000 (78/260) |
2.85E-14 |
B lymphocyte kinase (BLK)
|
|
25.926 (63/243) |
3.16E-14 |
Ephrin type-A receptor 10 (EPHA10)
|
|
27.542 (65/236) |
3.37E-14 |
Renal carcinoma antigen NY-REN-64 (IRAK-4)
|
|
25.490 (52/204) |
4.58E-14 |
Fibroblast growth factor receptor 3 (FGFR3)
|
|
26.357 (68/258) |
4.77E-14 |
Fyn tyrosine protein kinase (FYN)
|
|
24.671 (75/304) |
5.00E-14 |
Proto-oncogene c-Fer (FER)
|
|
29.412 (65/221) |
5.36E-14 |
Ephrin type-B receptor 1 (EPHB1)
|
|
25.769 (67/260) |
5.40E-14 |
Serine/threonine-protein kinase B-raf (BRAF)
|
|
26.027 (57/219) |
8.03E-14 |
Ephrin type-A receptor 7 (EPHA7)
|
|
26.991 (61/226) |
1.12E-13 |
MLK-related kinase (MLTK)
|
|
25.287 (66/261) |
1.17E-13 |
Yes tyrosine kinase (YES)
|
|
22.917 (55/240) |
1.29E-13 |
Ephrin type-A receptor 3 (EPHA3)
|
|
25.573 (67/262) |
1.32E-13 |
NT-3 growth factor receptor (TrkC)
|
|
25.939 (76/293) |
1.81E-13 |
Macrophage-stimulating protein receptor (RON)
|
|
25.410 (62/244) |
2.04E-13 |
Ephrin type-A receptor 4 (EPHA4)
|
|
28.761 (65/226) |
4.37E-13 |
Non-receptor tyrosine-protein kinase TNK1 (TNK1)
|
|
26.364 (58/220) |
6.91E-13 |
Ephrin type-A receptor 5 (EPHA5)
|
|
25.954 (68/262) |
7.26E-13 |
Tyrosine-protein kinase Fgr (FGR)
|
|
22.182 (61/275) |
1.29E-12 |
Proto-oncogene c-Met (MET)
|
|
28.444 (64/225) |
1.33E-12 |
LCK tyrosine protein kinase (LCK)
|
|
23.237 (56/241) |
1.49E-12 |
Ephrin type-B receptor 4 (EPHB4)
|
|
25.000 (59/236) |
2.03E-12 |
Ephrin type-A receptor 8 (EPHA8)
|
|
25.417 (61/240) |
2.17E-12 |
Tropomyosin-related kinase A (TrkA)
|
|
25.974 (80/308) |
2.20E-12 |
Insulin receptor-related protein (INSRR)
|
|
23.264 (67/288) |
4.85E-12 |
Tyrosine-protein kinase TXK (TXK)
|
|
22.180 (59/266) |
5.11E-12 |
BDNF/NT-3 growth factors receptor (TrkB)
|
|
24.126 (69/286) |
5.31E-12 |
Ephrin type-B receptor 3 (EPHB3)
|
|
24.719 (66/267) |
8.30E-12 |
Ephrin type-A receptor 1 (EPHA1)
|
|
25.368 (69/272) |
1.00E-11 |
Ephrin type-A receptor 2 (EPHA2)
|
|
25.556 (69/270) |
1.03E-11 |
Receptor-interacting serine/threonine-protein kinase 2 (RIPK2)
|
|
26.840 (62/231) |
1.21E-11 |
Mixed lineage kinase 2 (MAP3K10)
|
|
23.019 (61/265) |
1.28E-11 |
Tyrosine-protein kinase ZAP-70 (ZAP-70)
|
|
26.721 (66/247) |
1.91E-11 |
LIM domain kinase-1 (LIMK-1)
|
|
25.352 (54/213) |
1.97E-11 |
Tyrosine-protein kinase SYK (SYK)
|
|
26.222 (59/225) |
2.32E-11 |
Activated CDC42 kinase 1 (ACK-1)
|
|
25.506 (63/247) |
2.41E-11 |
Tyrosine-protein kinase Srms (SRMS)
|
|
26.293 (61/232) |
2.57E-11 |
TGF-beta receptor type II (TGFBR2)
|
|
29.680 (65/219) |
4.11E-11 |
Focal adhesion kinase 1 (FAK)
|
|
25.794 (65/252) |
6.38E-11 |
Ankyrin repeat and protein kinase domain-containing protein 1 (ANKK1)
|
|
23.045 (56/243) |
1.75E-10 |
Janus kinase 1 (JAK-1)
|
|
29.386 (67/228) |
1.93E-10 |
TYK2 tyrosine kinase (TYK2)
|
|
24.390 (70/287) |
4.51E-10 |
Ephrin type-A receptor 6 (EPHA6)
|
|
29.221 (45/154) |
5.04E-10 |
Insulin-like growth factor I receptor (IGF1R)
|
|
22.628 (62/274) |
5.69E-10 |
Focal adhesion kinase 2 (PTK2B)
|
|
22.469 (91/405) |
6.83E-10 |
Janus kinase 3 (JAK-3)
|
|
27.189 (59/217) |
7.87E-10 |
Discoidin domain-containing receptor 2 (DDR2)
|
|
24.895 (59/237) |
9.81E-10 |
Mixed lineage kinase 3 (MAP3K11)
|
|
24.277 (42/173) |
1.03E-09 |
Erbb4 tyrosine kinase receptor (Erbb-4)
|
|
24.651 (53/215) |
1.06E-09 |
Mixed lineage kinase 4 (MAP3K21)
|
|
33.628 (38/113) |
1.19E-09 |
Janus kinase 2 (JAK-2)
|
|
26.289 (51/194) |
1.27E-09 |
Angiopoietin 1 receptor (TEK)
|
|
23.846 (62/260) |
1.54E-09 |
ALK tyrosine kinase receptor (ALK)
|
|
24.219 (62/256) |
1.93E-09 |
Testis-specific kinase 2 (TESK2)
|
|
27.152 (41/151) |
2.23E-09 |
Proto-oncogene c-Ros (ROS1)
|
|
24.000 (66/275) |
2.26E-09 |
Bone morphogenetic protein receptor type-1A (BMPR1A)
|
|
25.589 (76/297) |
2.26E-09 |
LIM domain kinase-2 (LIMK-2)
|
|
24.091 (53/220) |
3.24E-09 |
Inactive tyrosine-protein kinase 7 (PTK7)
|
|
20.000 (50/250) |
4.29E-09 |
Testis-specific kinase 1 (TESK1)
|
|
22.449 (44/196) |
6.04E-09 |
Epidermal growth factor receptor (EGFR)
|
|
25.847 (61/236) |
6.97E-09 |
Dual serine/threonine and tyrosine protein kinase (DSTYK)
|
|
26.442 (55/208) |
7.37E-09 |
Platelet-derived growth factor receptor beta (PDGFRB)
|
|
28.058 (39/139) |
7.55E-09 |
Leukocyte receptor tyrosine kinase (LTK)
|
|
24.125 (62/257) |
8.32E-09 |
Epithelial discoidin domain receptor 1 (DDR1)
|
|
25.121 (52/207) |
9.91E-09 |
Serine/threonine-protein kinase LMTK1 (AATK)
|
|
25.000 (52/208) |
1.23E-08 |
Tyrosine-protein kinase STYK1 (STYK1)
|
|
27.586 (40/145) |
2.49E-08 |
Erbb2 tyrosine kinase receptor (HER2)
|
|
24.545 (54/220) |
2.75E-08 |
Neurotrophic tyrosine kinase ROR1 (ROR1)
|
|
24.051 (57/237) |
4.31E-08 |
TYRO3 tyrosine kinase receptor (TYRO3)
|
|
23.759 (67/282) |
5.26E-08 |
Mixed lineage kinase domain-like protein (MLKL)
|
|
25.735 (35/136) |
6.11E-08 |
Erbb3 tyrosine kinase receptor (Erbb-3)
|
|
22.927 (47/205) |
1.60E-07 |
Insulin receptor (INSR)
|
|
21.739 (50/230) |
1.82E-07 |
Platelet-derived growth factor receptor alpha (PDGFRA)
|
|
25.478 (40/157) |
4.27E-07 |
Serine/threonine-protein kinase TNNI3K (TNNI3K)
|
|
27.619 (58/210) |
4.39E-07 |
Bone morphogenetic protein receptor type-1B (BMPR1B)
|
|
27.519 (71/258) |
5.05E-07 |
Tyrosine-protein kinase UFO (AXL)
|
|
24.176 (66/273) |
5.51E-07 |
Serine/threonine-protein kinase LMTK2 (LMTK2)
|
|
23.415 (48/205) |
7.47E-07 |
Serine/threonine-protein kinase LMTK3 (LMTK3)
|
|
25.405 (47/185) |
2.16E-06 |
Activin receptor-like kinase-1 (ACVRL1)
|
|
24.519 (51/208) |
2.31E-06 |
Tyrosine-protein kinase Mer (MERTK)
|
|
23.684 (63/266) |
2.44E-06 |
Neurotrophic tyrosine kinase ROR2 (ROR2)
|
|
23.697 (50/211) |
2.50E-06 |
Muscle-specific kinase receptor (MUSK)
|
|
22.785 (54/237) |
3.39E-06 |
Activin receptor-like kinase 2 (ALK-2)
|
|
24.519 (51/208) |
5.05E-06 |
Kinase suppressor of Ras 2 (KSR2)
|
|
23.364 (50/214) |
5.90E-06 |
Fms-like tyrosine kinase 3 (FLT-3)
|
|
29.268 (36/123) |
1.01E-05 |
Tyrosine-protein kinase Kit (KIT)
|
|
28.319 (32/113) |
1.37E-05 |
Tyrosine-protein kinase RYK (RYK)
|
|
25.166 (38/151) |
1.51E-05 |
Macrophage colony-stimulating factor 1 receptor (CSF1R)
|
|
24.176 (44/182) |
1.77E-05 |
Vascular endothelial growth factor receptor 2 (KDR)
|
|
25.000 (40/160) |
1.77E-05 |
Vascular endothelial growth factor receptor 1 (FLT-1)
|
|
28.947 (33/114) |
2.73E-05 |
Vascular endothelial growth factor receptor 3 (FLT-4)
|
|
26.786 (30/112) |
4.09E-05 |
Soluble guanylyl cyclase (GUCY2D)
|
|
22.596 (47/208) |
8.38E-05 |
Integrin-linked protein kinase 1 (ILK)
|
|
26.786 (30/112) |
7.88E-04 |
Retinal guanylyl cyclase 2 (GUCY2F)
|
|
22.886 (46/201) |
2.00E-03 |
Kinase suppressor of Ras-1 (KSR1)
|
|
20.000 (44/220) |
2.00E-03 |
Activin receptor type-1C (ACVR1C)
|
|
24.402 (51/209) |
5.00E-03 |
Click to Show/Hide the Information of Human Similarity Proteins |